Skip to main content

Spyre Therapeutics, Inc.

SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636282

In the last 90 days, Spyre Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 265 institutions reported holding it in 13F filings for Q2 2026, worth $8.52B in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Spyre Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
131
+13 vs. Q3 2024
Shares held
59.9M
+8.57M (+16.7%) vs. Q3 2024
Total value
$1.39B
−$116.0M (−7.7%) vs. Q3 2024
New holders
34
63 more added
Sold out
21
20 more reduced

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 131 institutions
Q1 2021: 84 institutionsQ2 2021: 78 institutionsQ3 2021: 77 institutionsQ4 2021: 86 institutionsQ1 2022: 84 institutionsQ2 2022: 67 institutionsQ3 2022: 55 institutionsQ4 2022: 51 institutionsQ1 2023: 45 institutionsQ2 2023: 44 institutionsQ3 2023: 29 institutionsQ4 2023: 54 institutionsQ1 2024: 103 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 129 institutionsQ2 2025: 129 institutionsQ3 2025: 137 institutionsQ4 2025: 153 institutionsQ1 2026: 198 institutionsQ2 2026: 265 institutions
Value heldQ4 2024: $1.39B
Q1 2021: $328.7MQ2 2021: $285.8MQ3 2021: $322.5MQ4 2021: $189.4MQ1 2022: $95.4MQ2 2022: $24.8MQ3 2022: $23.5MQ4 2022: $19.2MQ1 2023: $12.0MQ2 2023: $31.9MQ3 2023: $43.9MQ4 2023: $601.0MQ1 2024: $1.21BQ2 2024: $1.18BQ3 2024: $1.51BQ4 2024: $1.39BQ1 2025: $1.00BQ2 2025: $952.6MQ3 2025: $1.08BQ4 2025: $2.65BQ1 2026: $4.16BQ2 2026: $8.52B
Institutions holding SYRE and their total value by quarter
QuarterHoldersValue
Q2 2026265$8.52B
Q1 2026198$4.16B
Q4 2025153$2.65B
Q3 2025137$1.08B
Q2 2025129$952.6M
Q1 2025129$1.00B
Q4 2024131$1.39B
Q3 2024119$1.51B
Q2 2024107$1.18B
Q1 2024103$1.21B
Q4 202354$601.0M
Q3 202329$43.9M
Q2 202344$31.9M
Q1 202345$12.0M
Q4 202251$19.2M
Q3 202255$23.5M
Q2 202267$24.8M
Q1 202284$95.4M
Q4 202186$189.4M
Q3 202177$322.5M
Q2 202178$285.8M
Q1 202184$328.7M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Spyre Therapeutics, Inc.; share changes are against Q3 2024.

Institutions holding SYRE in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Emerald Mutual Fund Advisers Trust386,384$9.00M0.55%+132,834+52.4%Added
UBS Group AG392,197$9.13M0.00%+334,359+578.1%Added
Blackstone Group Inc.449,201$10.5M0.05%+156,206+53.3%Added
Deerfield Management Company, L.P. (Series C)450,000$10.5M0.20%+450,000New
Boxer Capital Management, LLC466,680$10.9M0.93%+466,680New
Logos Global Management LP500,000$11.6M1.36%+300,000+150.0%Added
Price T Rowe Associates Inc506,450$11.8M0.00%+77,323+18.0%Added
Emerald Advisers, LLC546,791$12.7M0.49%+254,222+86.9%Added
Goldman Sachs Group Inc747,552$17.4M0.00%+578,238+341.5%Added
Polar Capital Holdings Plc750,000$17.5M0.10%+250,000+50.0%Added
Franklin Resources Inc760,642$17.7M0.00%−240.0%Reduced
Affinity Asset Advisors, LLC824,328$19.2M3.00%+325,908+65.4%Added
Geode Capital Management, LLC966,129$22.5M0.00%+75,081+8.4%Added
Adage Capital Partners GP, L.L.C.1,030,000$24.0M0.04%−25,000−2.4%Reduced
Citadel Advisors LLC1,079,307$25.1M0.02%+371,721+52.5%Added
Pictet Asset Management Holding SA1,092,124$25.4M0.03%+266,418+32.3%Added
Jefferies Financial Group Inc.1,216,954$28.3M0.32%+762,147+167.6%Added
Janus Henderson Group PLC1,456,740$33.9M0.02%+336,209+30.0%Added
Paradigm Biocapital Advisors LP1,527,205$35.6M1.24%+259,624+20.5%Added
Wellington Management Group LLP1,604,508$37.4M0.01%+97,308+6.5%Added
State Street Corp1,680,936$39.1M0.00%+139,381+9.0%Added
Commodore Capital LP1,988,084$46.3M3.39%00.0%Unchanged
Perceptive Advisors LLC2,574,723$59.9M1.67%−297,824−10.4%Reduced
Braidwell LP2,578,404$60.0M1.78%+388,568+17.7%Added
VR Adviser, LLC2,685,448$62.5M4.29%00.0%Unchanged
Driehaus Capital Management LLC2,803,655$65.3M0.54%+2,116,575+308.1%Added
Vanguard Group Inc2,846,473$66.3M0.00%+330,553+13.1%Added
BlackRock, Inc.3,399,591$79.1M0.00%+736,444+27.7%Added
RTW Investments, LP3,621,996$84.3M1.28%+363,636+11.2%Added
Fairmount Funds Management LLC4,018,101$93.5M9.30%00.0%Unchanged
FMR LLC8,801,266$204.9M0.01%+1,177,385+15.4%Added
Boxer Capital, LLC0$00.00%−696,480−100.0%Sold out
Avoro Capital Advisors LLC0$00.00%−598,600−100.0%Sold out
Walleye Capital LLC0$00.00%−243,372−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−227,950−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−46,072−100.0%Sold out
Superstring Capital Management LP0$00.00%−37,287−100.0%Sold out
AQR Capital Management LLC0$00.00%−35,003−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−31,138−100.0%Sold out
Jane Street Group, LLC0$00.00%−20,641−100.0%Sold out
SG Americas Securities, LLC0$00.00%−12,589−100.0%Sold out
ADAR1 Capital Management, LLC0$00.00%−12,560−100.0%Sold out
Acadian Asset Management LLC0$00.00%−814−100.0%Sold out
nVerses Capital, LLC0$00.00%−500−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−129−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−46−100.0%Sold out
Bessemer Group Inc0$00.00%−45−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−19−100.0%Sold out
True Wealth Design, LLC0$00.00%−16−100.0%Sold out
US Bancorp0$00.00%−9−100.0%Sold out
GAMMA Investing LLC0$00.00%−5−100.0%Sold out
National Bank of Canada0$00.00%−1−100.0%Sold out
Ghost Tree Capital, LLC––––Not filed